Lupin informs about press release

16 Jun 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, the Company having signed a license and supply agreement with Sino Universal Pharmaceuticals, for the commercialization of Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese market, for the treatment of chronic obstructive pulmonary disease.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2096.45 -16.50 (-0.78%)
29-Dec-2025 12:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.80
Dr. Reddys Lab 1262.90
Cipla 1500.50
Zydus Lifesciences 904.60
Lupin 2096.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×